Tarsus pharmaceuticals inc.

Other-Pharmaceuticals

TARS


15440 Laguna Canyon Road
Irvine , CA 92618

Executive/
Director

Price

  • Last Close
  • $ 55.61
    $ +0.5 0.91 %
    Jan 3, 2025
  • 52-Week High/Low
  • $39.22 - $12.98
  • YTD
  • 0.4%

  • Trading Volume
  • 26,979
  • Market Cap Full
  • $ 1.8B
  • Shares Outstanding
  • 33.1M
    Nov 3, 2023
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Q1 - - - - -5% -22.7% -28.3% -14.3% 79.3% 0.4%
Q2 - - - - 4% -9.3% -13.2% 43.8% -30% -
Q3 - - - - 8% -25.6% 17.3% -1.7% 13.1% -
Q4 - - - - 100.8% 8.8% -14.4% 16.1% 9.2% -
J F M A M J J A S O N D
2025 0.4% - - - - - - - - - - -
2024 34.5% 40.3% -5% -10.8% 1.9% -23.7% -3.7% 13.1% - - - -
    2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
    0%0%0%0%0%0%-43%-37%38%174%0%

Earnings

2020 2021 2022 2023
Q1 - 0.47 -0.98 -0.88
Q2 - 0.29 -0.24 -1.17
Q3 - -0.76 -0.84 -1.28
Q4 - -0.67 -0.46 -
A -4.3 -0.7 -2.5 -3.33

Annual Returns

52 Week
High/Low

Annual
Earnings

Chart

Trading Volume

2020 2021 2022 2023
Mar - 20.5 20.7 26.7
Jun - 20.5 20.7 26.8
Sep - 20.6 26.7 32.6
Dec 20.3 20.7 26.7 33.1

Financial Ratios

20222021202020192018
Asset Management
Inventory / Stock Turnover - - - - -
Fixed Asset Turnover 13 28.5 - - -
Total Asset Turnover 0.1 0.3 - - -
Leverage
Debt Ratio 0.1 - - - -
Debt – Equity Ratio 0.1 - - - -
Interest Coverage 63 -6 - -4 -
Equity multiplier - - - - -